TY - JOUR
T1 - Views of health journalists, industry employees and news consumers about disclosure and regulation of industry-journalist relationships
T2 - an empirical ethical study
AU - Lipworth, Wendy
AU - Kerridge, Ian
AU - Morrell, Bronwen
AU - Forsyth, Rowena
AU - Jordens, Christopher F C
N1 - Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
PY - 2015/3
Y1 - 2015/3
N2 - Bioethicists and policymakers are increasingly concerned about the effects on health journalism of relationships between journalists and private corporations. The concern is that relationships between journalists and manufacturers of medicines, medical devices, complementary medicines and food can and do distort health reporting. This is a problem because health news is known to have a major impact on the public's health-related expectations and behaviour. Commentators have proposed two related approaches to protecting the public from potential harms arising from industry-journalist interactions: greater transparency and external regulation. To date, few empirical studies have examined stakeholders' views of industry-journalist relationships and how these should be managed. We conducted interviews with 13 journalists and 12 industry employees, and 2 focus groups with consumers. Our findings, which are synthesised here, provide empirical support for the need for greater transparency and regulation of industry-journalist relationships. Our findings also highlight several likely barriers to instituting such measures, which will need to be overcome if transparency and regulation are to be accepted by stakeholders and have their intended effect on the quality of journalism and the actions of news consumers.
AB - Bioethicists and policymakers are increasingly concerned about the effects on health journalism of relationships between journalists and private corporations. The concern is that relationships between journalists and manufacturers of medicines, medical devices, complementary medicines and food can and do distort health reporting. This is a problem because health news is known to have a major impact on the public's health-related expectations and behaviour. Commentators have proposed two related approaches to protecting the public from potential harms arising from industry-journalist interactions: greater transparency and external regulation. To date, few empirical studies have examined stakeholders' views of industry-journalist relationships and how these should be managed. We conducted interviews with 13 journalists and 12 industry employees, and 2 focus groups with consumers. Our findings, which are synthesised here, provide empirical support for the need for greater transparency and regulation of industry-journalist relationships. Our findings also highlight several likely barriers to instituting such measures, which will need to be overcome if transparency and regulation are to be accepted by stakeholders and have their intended effect on the quality of journalism and the actions of news consumers.
UR - http://www.scopus.com/inward/record.url?scp=84923221519&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/nhmrc/632840
U2 - 10.1136/medethics-2013-101790
DO - 10.1136/medethics-2013-101790
M3 - Article
C2 - 24603036
SN - 0306-6800
VL - 41
SP - 252
EP - 257
JO - Journal of Medical Ethics
JF - Journal of Medical Ethics
IS - 3
ER -